Ipca Laboratories acquires 100 per cent stake in Onyx Research ChemicalsIllustrative image – not actual.

Ipca Laboratories through its wholly owned subsidiary Ipca Laboratories UK has acquired 100 per cent share capital of Onyx Research Chemicals, holding company of Onyx Scientific. 

 

Financial details of the deal have not been disclosed. Onyx Scientific will continue to operated from its UK facility. Onyx’s capabilities  in chemistry services  for medicinal, preclinical, and Phase I/II program will combine effectively with Ipca’s capabilities in supporting Phase II of commercial scale programmes.

← All latest storiesBack to top →